Fieldview Capital Management LLC Makes New Investment in HealthEquity, Inc. $HQY

Fieldview Capital Management LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 6,486 shares of the company’s stock, valued at approximately $594,000.

Other large investors have also bought and sold shares of the company. Acumen Wealth Advisors LLC purchased a new position in HealthEquity in the fourth quarter worth about $27,000. Caitong International Asset Management Co. Ltd raised its holdings in HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares during the last quarter. Torren Management LLC purchased a new position in HealthEquity in the fourth quarter worth about $40,000. Northwestern Mutual Wealth Management Co. raised its holdings in HealthEquity by 190.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock worth $55,000 after buying an additional 396 shares during the last quarter. Finally, Larson Financial Group LLC raised its holdings in HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after buying an additional 123 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. This represents a 7.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This represents a 5.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 13,081 shares of company stock valued at $1,193,000. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on HQY. Raymond James Financial set a $100.00 target price on shares of HealthEquity in a report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Citizens Jmp lifted their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a report on Monday, June 1st. Finally, Barrington Research reissued an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Stock Down 1.6%

HQY opened at $86.97 on Tuesday. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a 50 day moving average price of $84.69 and a 200-day moving average price of $85.62. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $106.60. The stock has a market capitalization of $7.27 billion, a price-to-earnings ratio of 32.57, a PEG ratio of 1.49 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.